Fractional Flow Reserve Market Research and Forecast Report 2023-2028

1. Global Fractional Flow Reserve Market Research and Forecast Report 2023- 2028 Author: Elena Anderson, Marketing Manager | Copyright © IMARC Service Pvt Ltd. All Rights Reserved IMARC Group © 2019 IMARC All Rights Reserved

2. Report DescriptionAbout IMARC Group The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

3. Report Description and Highlights Report Description Global Fractional Flow Reserve Market Research Report: The latest report by IMARC, titled “Fractional Flow Reserve Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” " the global fractional flow reserve market is expected to exhibit a CAGR of 11.9% during 2023-2028. Fractional flow reserve (FFR) refers to an invasive guide wire-based procedure that is employed to measure the blood pressure and flow through a specific part of the coronary artery. It is utilized in coronary catheterization to calculate the pressure differences across coronary artery stenosis. Its usage aids in determining the possibility of the stenosis impeding the delivery of oxygen to the heart by analyzing the ratio between the maximum achievable blood flow in a diseased coronary artery and the theoretical maximum flow in a normal coronary artery. It is essential for assessing if the patient requires angioplasty or stenting on intermediate blockages. It is widely recommended by healthcare professionals as this procedure assists in avoiding unnecessary surgeries, such as a stent or bypass surgery, while saving costs. Request market/requestsample Free Sample Report: https://www.imarcgroup.com/fractional-flow-reserve-

4. Report Description and Highlights Report Description Global Fractional Flow Reserve Market Trends: The market is primarily driven by the increasing incidences of cardiovascular diseases (CVDs), such as coronary artery diseases and high blood pressure, across the globe. FFR is extensively recommended by healthcare professionals for assessing the possibility of stenosis that can be responsible for inducible ischemia. This, in turn, is creating a positive outlook for the market. There has also been a significant rise in the occurrence of several chronic diseases, including type II diabetes. This can be accredited to the sedentary lifestyle patterns and increasing consumption of fast food among the masses. Since type II diabetes can often lead to the development of fatty cells in the coronary artery of the patients and result in blockages, further causing a stroke or a heart attack, this is, therefore, expected to catalyze the demand for FFR on the global level. The market is further driven by the rising geriatric population as the elderly are more prone to developing CVDs and diabetes. Moreover, the increasing number of favorable clinical outcomes for percutaneous coronary intervention (PCI) guided by FFR are creating a positive outlook for the market. This, along with rising investments in research and development (R&D) activities, is contributing to the market growth further. Looking forward, the market value is projected to reach a strong growth during the forecast period (2023-2028).

5. Report Description and Highlights Report Description Market Summary: Breakup by Product: • FFR Guidewires • FFR Monitoring Systems Breakup by Application: • Multi-Vessel Coronary Artery Disease • Single-Vessel Coronary Artery Disease Breakup by End User: • Hospitals and Ambulatory Surgery Centers • Diagnostic Centers • Others Breakup by Region: • North America • United States • Canada • Asia Pacific

6. Report Description and Highlights Report Description • China • Japan • India • South Korea • Australia • Indonesia • Others • Europe • Germany • France • United Kingdom • Italy • Spain • Russia • Others • Latin America • Brazil • Mexico • Others • Middle East and Africa

7. Report Description and Highlights Report Description Competitive Landscape with Key Players: • • • • • • • • • Abbott Laboratories ACIST Medical Systems Inc. (Bracco S.p.A.) Boston Scientific Corporation CathWorks Inc. Heartflow Inc. Koninklijke Philips N.V. Opsens Solutions Pie Medical Imaging B.V. (Esaote Group) Siemens Healthcare Private Limited (Siemens AG) View Full Report with TOC & List of Figure: https://www.imarcgroup.com/fractional-flow-reserve- market

8. We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients

9. We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients

10. Report Description and Highlights Report Description © 2019 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

11. Contact Us FOR MORE DETAILS Visit us at : https://www.imarcgroup.com Stay With Us: TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com